CA1330185C - Soudure torsadee - Google Patents

Soudure torsadee

Info

Publication number: CA1330185C
Authority: CA; Canada
Prior art keywords: suture; braided; braided suture; denier; fabricated
Prior art date: 1987-08-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA 575697

Other languages

English (en)

Inventor

Donald S. Kaplan

Matthew E. Hermes

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

United States Surgical Corp

Original Assignee

United States Surgical Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-08-26

Filing date

1988-08-26

Publication date

1994-06-14

1988-08-26 Application filed by United States Surgical Corp filed Critical United States Surgical Corp

1994-06-14 Application granted granted Critical

1994-06-14 Publication of CA1330185C publication Critical patent/CA1330185C/fr

2011-06-14 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

238000010276 construction Methods 0.000 claims description 19
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 16
239000000463 material Substances 0.000 claims description 9
RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims description 8
235000014655 lactic acid Nutrition 0.000 claims description 8
239000004310 lactic acid Substances 0.000 claims description 8
JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims description 8
239000000178 monomer Substances 0.000 claims description 8
-1 silk Polymers 0.000 claims description 6
239000004952 Polyamide Substances 0.000 claims description 4
229920002647 polyamide Polymers 0.000 claims description 4
229920000742 Cotton Polymers 0.000 claims description 3
230000001747 exhibiting effect Effects 0.000 claims description 3
229920000098 polyolefin Polymers 0.000 claims description 3
239000000126 substance Substances 0.000 claims description 3
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims 14
229920000642 polymer Polymers 0.000 claims 14
230000002708 enhancing effect Effects 0.000 claims 2
210000001519 tissue Anatomy 0.000 description 5
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
208000027418 Wounds and injury Diseases 0.000 description 3
229920001577 copolymer Polymers 0.000 description 3
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
229920000954 Polyglycolide Polymers 0.000 description 2
208000007536 Thrombosis Diseases 0.000 description 2
229920002988 biodegradable polymer Polymers 0.000 description 2
239000004621 biodegradable polymer Substances 0.000 description 2
239000008199 coating composition Substances 0.000 description 2
239000008358 core component Substances 0.000 description 2
239000003814 drug Substances 0.000 description 2
239000000835 fiber Substances 0.000 description 2
239000003102 growth factor Substances 0.000 description 2
229920000728 polyester Polymers 0.000 description 2
239000004633 polyglycolic acid Substances 0.000 description 2
230000001737 promoting effect Effects 0.000 description 2
229940124597 therapeutic agent Drugs 0.000 description 2
230000008467 tissue growth Effects 0.000 description 2
230000037314 wound repair Effects 0.000 description 2
VPVXHAANQNHFSF-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1 VPVXHAANQNHFSF-UHFFFAOYSA-N 0.000 description 1
LCSKNASZPVZHEG-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1.CC1OC(=O)C(C)OC1=O LCSKNASZPVZHEG-UHFFFAOYSA-N 0.000 description 1
208000031504 Asymptomatic Infections Diseases 0.000 description 1
108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
229920004937 Dexon® Polymers 0.000 description 1
101800003838 Epidermal growth factor Proteins 0.000 description 1
102400001368 Epidermal growth factor Human genes 0.000 description 1
IWDQPCIQCXRBQP-UHFFFAOYSA-M Fenaminosulf Chemical compound [Na+].CN(C)C1=CC=C(N=NS([O-])(=O)=O)C=C1 IWDQPCIQCXRBQP-UHFFFAOYSA-M 0.000 description 1
102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
229930182566 Gentamicin Natural products 0.000 description 1
102000002068 Glycopeptides Human genes 0.000 description 1
108010015899 Glycopeptides Proteins 0.000 description 1
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
102000014150 Interferons Human genes 0.000 description 1
108010050904 Interferons Proteins 0.000 description 1
102100020873 Interleukin-2 Human genes 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
108060003100 Magainin Proteins 0.000 description 1
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
102000019197 Superoxide Dismutase Human genes 0.000 description 1
108010012715 Superoxide dismutase Proteins 0.000 description 1
102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
229920006167 biodegradable resin Polymers 0.000 description 1
238000006065 biodegradation reaction Methods 0.000 description 1
230000008468 bone growth Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
229940116977 epidermal growth factor Drugs 0.000 description 1
229960003276 erythromycin Drugs 0.000 description 1
229940126864 fibroblast growth factor Drugs 0.000 description 1
230000012010 growth Effects 0.000 description 1
230000035876 healing Effects 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
238000007373 indentation Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
208000014674 injury Diseases 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
238000001000 micrograph Methods 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
238000011275 oncology therapy Methods 0.000 description 1
229920000747 poly(lactic acid) Polymers 0.000 description 1
229920000139 polyethylene terephthalate Polymers 0.000 description 1
239000005020 polyethylene terephthalate Substances 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920005989 resin Polymers 0.000 description 1
239000011347 resin Substances 0.000 description 1
238000001878 scanning electron micrograph Methods 0.000 description 1
238000004626 scanning electron microscopy Methods 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
230000003746 surface roughness Effects 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
230000008733 trauma Effects 0.000 description 1
YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 1
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1

Landscapes

Materials For Medical Uses (AREA)

CA 575697 1987-08-26 1988-08-26 Soudure torsadee Expired - Lifetime CA1330185C (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US8973287A	1987-08-26	1987-08-26
US089,732		1987-08-26
US22769988A	1988-08-03	1988-08-03
US227,699		1988-08-03

Publications (1)

Publication Number	Publication Date
CA1330185C true CA1330185C (fr)	1994-06-14

Family

ID=26780893

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 575697 Expired - Lifetime CA1330185C (fr)	1987-08-26	1988-08-26	Soudure torsadee

Country Status (1)

Country	Link
CA (1)	CA1330185C (fr)

1988
- 1988-08-26 CA CA 575697 patent/CA1330185C/fr not_active Expired - Lifetime

Legal Events

Date	Code	Title	Description
2011-06-14	MKEX	Expiry	Effective date: 20110614

Publication	Publication Date	Title
US5019093A (en)	1991-05-28	Braided suture
US5261886A (en)	1993-11-16	Cabled core and braided suture made therefrom
EP0625356B1 (fr)	2000-02-02	Suture tressée
EP1506789B1 (fr)	2009-10-07	Fils hétérogènes pour articles chirurgicaux
EP0472260B2 (fr)	2004-04-28	Suture tressée ayant des caractéristiques améliorées
US5662682A (en)	1997-09-02	Spiroid braided suture
US5423859A (en)	1995-06-13	Jet entangled suture yarn and method for making same
US5226912A (en)	1993-07-13	Combined surgical needle-braided suture device
EP0557894B1 (fr)	1997-07-30	Tresse stérilisé hétérogène
US20100016891A1 (en)	2010-01-21	Heterogeneous yarns for surgical articles
EP0485986A1 (fr)	1992-05-20	Prothèse pour tissu conjonctif
EP0523743B1 (fr)	1996-04-17	Toron stérilisé de fibres à deux composants
AU657725B2 (en)	1995-03-23	Cabled core and braided suture made therefrom
AU2003293072B2 (en)	2008-03-20	Method for making fast absorbing sutures by hydrolysis
AU648292B2 (en)	1994-04-21	Braided suture of improved characteristics
TWM647997U (zh)	2023-11-01	可持久暫留皮膚的縫線
US20100323961A1 (en)	2010-12-23	Surface eroding sutures